| Dr Richard Eric Miller, MD | |
|
513-c Brookman Dr, Brookhaven, MS 39601-2399 | |
| (601) 833-3822 | |
| (601) 835-4330 |
| Full Name | Dr Richard Eric Miller |
|---|---|
| Gender | Male |
| Speciality | Nephrology |
| Experience | 17 Years |
| Location | 513-c Brookman Dr, Brookhaven, Mississippi |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053533406 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RN0300X | Internal Medicine - Nephrology | 18980 (Mississippi) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Rcg Brookhaven | Brookhaven, MS | Dialysis facility |
| Rcg Mccomb | Mccomb, MS | Dialysis facility |
| King's Daughters Medical Center-brookhaven | Brookhaven, MS | Hospital |
| Southwest Ms Regional Medical Center | Mccomb, MS | Hospital |
| Merit Health Natchez | Natchez, MS | Hospital |
| Copiah County Medical Center | Hazlehurst, MS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Southwest Ms Nephrology, Pllc | 0345203857 | 4 |
News Archive
A research team led by Children's National Medical Center has identified a trigger that causes latent Kaposi's sarcoma-associated herpesvirus (KSHV) to rapidly replicate itself. KSHV causes Kaposi's sarcoma, primary effusion lymphoma, and other cancers that commonly affect immunocompromised patients, including those with AIDS.
Researchers from Boston Medical Center and Boston University School of Public Health have found that individuals who do not speak English at home are less likely to receive colorectal cancer screenings as compared to those who do speak English at home. The findings, which currently appear on-line in the Journal of General Internal Medicine, suggest that patient-provider language barriers play a role in health-care disparities, and that providers should promote the importance of CRC screening to non-English speaking patients.
Critically ill patients with metabolic acidosis are twice as likely to die as patients who do not have metabolic acidosis.
Roche OSI Pharmaceuticals and Genentech today announced that their investigational drug Tarceva(TM) (erlotinib) achieved a significant 42.5% improvement in median survival compared to placebo in patients with advanced non-small cell lung cancer (NSCLC).
Cells lining the intestinal tract form a critical barrier, protecting our bodies from the billions of bacteria living in the gut. Breaches in this barrier are driven largely by a single signaling molecule called tumor necrosis factor (TNF), elevated amounts of which are associated with inflammatory bowel diseases like Crohn's disease and ulcerative colitis.
› Verified 6 days ago
| Entity Name | Southwest Ms Nephrology, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396894234 PECOS PAC ID: 0345203857 Enrollment ID: O20041105000657 |
News Archive
A research team led by Children's National Medical Center has identified a trigger that causes latent Kaposi's sarcoma-associated herpesvirus (KSHV) to rapidly replicate itself. KSHV causes Kaposi's sarcoma, primary effusion lymphoma, and other cancers that commonly affect immunocompromised patients, including those with AIDS.
Researchers from Boston Medical Center and Boston University School of Public Health have found that individuals who do not speak English at home are less likely to receive colorectal cancer screenings as compared to those who do speak English at home. The findings, which currently appear on-line in the Journal of General Internal Medicine, suggest that patient-provider language barriers play a role in health-care disparities, and that providers should promote the importance of CRC screening to non-English speaking patients.
Critically ill patients with metabolic acidosis are twice as likely to die as patients who do not have metabolic acidosis.
Roche OSI Pharmaceuticals and Genentech today announced that their investigational drug Tarceva(TM) (erlotinib) achieved a significant 42.5% improvement in median survival compared to placebo in patients with advanced non-small cell lung cancer (NSCLC).
Cells lining the intestinal tract form a critical barrier, protecting our bodies from the billions of bacteria living in the gut. Breaches in this barrier are driven largely by a single signaling molecule called tumor necrosis factor (TNF), elevated amounts of which are associated with inflammatory bowel diseases like Crohn's disease and ulcerative colitis.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Richard Eric Miller, MD 4701 Lakeland Dr, Apt 28-c, Flowood, MS 39232-9506 Ph: (601) 405-1593 | Dr Richard Eric Miller, MD 513-c Brookman Dr, Brookhaven, MS 39601-2399 Ph: (601) 833-3822 |
News Archive
A research team led by Children's National Medical Center has identified a trigger that causes latent Kaposi's sarcoma-associated herpesvirus (KSHV) to rapidly replicate itself. KSHV causes Kaposi's sarcoma, primary effusion lymphoma, and other cancers that commonly affect immunocompromised patients, including those with AIDS.
Researchers from Boston Medical Center and Boston University School of Public Health have found that individuals who do not speak English at home are less likely to receive colorectal cancer screenings as compared to those who do speak English at home. The findings, which currently appear on-line in the Journal of General Internal Medicine, suggest that patient-provider language barriers play a role in health-care disparities, and that providers should promote the importance of CRC screening to non-English speaking patients.
Critically ill patients with metabolic acidosis are twice as likely to die as patients who do not have metabolic acidosis.
Roche OSI Pharmaceuticals and Genentech today announced that their investigational drug Tarceva(TM) (erlotinib) achieved a significant 42.5% improvement in median survival compared to placebo in patients with advanced non-small cell lung cancer (NSCLC).
Cells lining the intestinal tract form a critical barrier, protecting our bodies from the billions of bacteria living in the gut. Breaches in this barrier are driven largely by a single signaling molecule called tumor necrosis factor (TNF), elevated amounts of which are associated with inflammatory bowel diseases like Crohn's disease and ulcerative colitis.
› Verified 6 days ago
Bryan S Calcote, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 527 Silver Cross Dr, Brookhaven, MS 39601 Phone: 601-835-0507 Fax: 601-835-2766 | |
Dr. James E Roberts, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 439 N Jackson St Ste D, Brookhaven, MS 39601 Phone: 601-833-2222 Fax: 601-823-3073 | |
Matthew T Gaines, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 427 Highway 51 N, Brookhaven, MS 39601 Phone: 601-833-6011 | |
Ramiro A Montalvo Jr., M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 940 Brookway Blvd, Brookhaven, MS 39601 Phone: 601-823-5000 Fax: 601-823-4140 | |
Dr. Blaine Cooper Britt, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 950 Brookway Blvd, Brookhaven, MS 39601 Phone: 601-833-7973 Fax: 601-823-3514 | |
Dena W Jackson, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 940 Brookway Blvd, Brookhaven, MS 39601 Phone: 601-823-5000 Fax: 601-823-4140 |